EFFACLAR K (+) renewing, antioxidant and anti-sebum corrective treatment 40 ml

€25.50
Tax included
Quantity

  Security policy

(edit with the Customer Reassurance module)

  Delivery policy

(edit with the Customer Reassurance module)

  Return policy

(edit with the Customer Reassurance module)

LA ROCHE POSAY presents Effaclar K(+), a special care solution aimed at individuals with oily skin facing imperfections. External factors such as pollution, tobacco smoke, and dust can lead to skin oxidation, resulting in conditions like hyperkeratinization, excessive sebum production, and the buildup of impurities. These issues often manifest as open pores, blackheads, and uneven skin texture. To tackle these concerns, the La Roche-Posay Research Department has developed Effaclar K+, a dermatological formula designed specifically for adult skin prone to acne. It acts as a skin renewer, antioxidant, and sebum-regulating product over a period of 8 hours. This treatment effectively detoxifies and purifies the skin, refining its texture while diminishing the appearance of pores, blackheads, and excess shine. Benefits are noticeable from the very first application, offering a refreshing and clean feel that lasts throughout the day. Over the course of one month, users can expect significant improvements, such as smoother skin texture, reduced pore visibility, and the elimination of shine. Clinical studies confirm its effectiveness in preventing the recurrence of blemishes and blackheads*. The formula is specifically tested for acne-prone skin, non-comedogenic, and boasts a non-greasy finish. *Results demonstrated after 3 weeks of treatment for an 8-week duration with a group of 47 participants.
897-13491
120 Items

Data sheet

Gender
Unisex
CompleteFamilies
Cosmética Facial/Tratamientos Faciales
Contenido
40 ml
Tendencias
LHA
Vitamina E
Ácido salicílico
Texturas
Gel
Formulación
No Comedogénico
Piel
Acneica
Grasa
Seborreica
Parafarmacia
Dermocosmética
Parafarmacia

Specific References

EAN13
3337875613491
Comments (0)
No customer reviews for the moment.